Strata Skin Sciences, Inc. (SSKN) Earns “Buy” Rating from HC Wainwright

Strata Skin Sciences, Inc. (NASDAQ:SSKN)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research note issued on Thursday, September 7th.

SSKN has been the topic of a number of other reports. Rodman & Renshaw increased their price target on Strata Skin Sciences from $1.50 to $12.00 and gave the stock a “buy” rating in a report on Tuesday, May 16th. ValuEngine raised Strata Skin Sciences from a “strong sell” rating to a “sell” rating in a research report on Friday, June 16th. Finally, Zacks Investment Research lowered Strata Skin Sciences from a “hold” rating to a “sell” rating in a research report on Wednesday, August 16th.

Shares of Strata Skin Sciences (NASDAQ:SSKN) traded up 4.14% during trading on Thursday, hitting $1.76. 18,391 shares of the company’s stock were exchanged. The firm’s market capitalization is $4.36 million. Strata Skin Sciences has a 1-year low of $0.43 and a 1-year high of $5.40. The stock’s 50 day moving average is $1.74 and its 200 day moving average is $2.03.

Strata Skin Sciences (NASDAQ:SSKN) last announced its earnings results on Thursday, August 10th. The medical device company reported ($0.52) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.71) by $0.19. Strata Skin Sciences had a negative return on equity of 41.58% and a negative net margin of 18.00%. The business had revenue of $8.70 million for the quarter, compared to analysts’ expectations of $7.98 million. On average, equities research analysts forecast that Strata Skin Sciences will post ($3.14) earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Strata Skin Sciences, Inc. (SSKN) Earns “Buy” Rating from HC Wainwright” was first published by BBNS and is owned by of BBNS. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at https://baseballnewssource.com/markets/hc-wainwright-reiterates-buy-rating-for-strata-skin-sciences-inc-sskn/1619691.html.

About Strata Skin Sciences

STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.

Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Bryce Harper Hoping to Return Monday from Knee Injury
Bryce Harper Hoping to Return Monday from Knee Injury
American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?


Leave a Reply

 
© 2006-2017 BBNS.